| Application no. and date | 99919169.5 (espacenet) (Federated) (European Patent Register), 19990401 | | Patent/reg. no. and date | DK/EP 1070078, 20030122 | | Publication date | 20010124 | | Priority no. and date | GB 9807355, 19980407 | | EP pub. no. and date |
EP 1070078 20010124 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House,
Berkeley Avenue
Greenford,
Middlesex UB6 0NN, GB | | Applicant ref. no. | 34700 DK 01 | | Inventor | CARTER, Barry, Howard, Glaxo Wellcome Inc.
Five Moore Drive
Research Triangle Park, NC 27709, US,
HODGSON, Anne, Glaxo Wellcome plc
Temple Hill
Dartford
Kent DA1 5AH, GB,
HUANG, Lian-Feng, Glaxo Wellcome Inc.
Five Moore Drive
Research Triangle Park, NC 27709, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/70, C07H 19/052 | | Title | Form VI 5,6-dichlor-2-(isopropylamino-)-1-beta-L-ribofuranosyl)-1H-benzimidazol | | Int. application no. | EP1999002213 | | Int. publication no. | WO1999051617 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
